Mitophagy suppression via lncRNA H19 silencing: a novel strategy to overcome cisplatin resistance in lung adenocarcinoma.
Saved in:
| Title: | Mitophagy suppression via lncRNA H19 silencing: a novel strategy to overcome cisplatin resistance in lung adenocarcinoma. |
|---|---|
| Authors: | Liu MZ; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China.; Department of Internal Medicine, Zhumadian Central Hospital, Zhumadian, China., Shao XY; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Wu SH; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Ning QQ; Department of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA., Zhang C; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Du WW; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Sun RR; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Sun SY; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Zhang YW; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China. |
| Source: | Cell cycle (Georgetown, Tex.) [Cell Cycle] 2025 Nov-Dec; Vol. 24 (21-24), pp. 670-686. Date of Electronic Publication: 2025 Nov 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1551-4005 (Electronic) Linking ISSN: 15514005 NLM ISO Abbreviation: Cell Cycle Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41194501 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mitophagy suppression via lncRNA H19 silencing: a novel strategy to overcome cisplatin resistance in lung adenocarcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liu+MZ%22">Liu MZ</searchLink>; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China.; Department of Internal Medicine, Zhumadian Central Hospital, Zhumadian, China.<br /><searchLink fieldCode="AU" term="%22Shao+XY%22">Shao XY</searchLink>; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China.<br /><searchLink fieldCode="AU" term="%22Wu+SH%22">Wu SH</searchLink>; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China.<br /><searchLink fieldCode="AU" term="%22Ning+QQ%22">Ning QQ</searchLink>; Department of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+C%22">Zhang C</searchLink>; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China.<br /><searchLink fieldCode="AU" term="%22Du+WW%22">Du WW</searchLink>; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China.<br /><searchLink fieldCode="AU" term="%22Sun+RR%22">Sun RR</searchLink>; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China.<br /><searchLink fieldCode="AU" term="%22Sun+SY%22">Sun SY</searchLink>; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+YW%22">Zhang YW</searchLink>; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101137841%22">Cell cycle (Georgetown, Tex.)</searchLink> [Cell Cycle] 2025 Nov-Dec; Vol. 24 (21-24), pp. 670-686. <i>Date of Electronic Publication: </i>2025 Nov 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101137841 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1551-4005 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215514005%22">15514005 </searchLink><i>NLM ISO Abbreviation: </i>Cell Cycle <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41194501 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/15384101.2025.2581634 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 670 Titles: – TitleFull: Mitophagy suppression via lncRNA H19 silencing: a novel strategy to overcome cisplatin resistance in lung adenocarcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu MZ – PersonEntity: Name: NameFull: Shao XY – PersonEntity: Name: NameFull: Wu SH – PersonEntity: Name: NameFull: Ning QQ – PersonEntity: Name: NameFull: Zhang C – PersonEntity: Name: NameFull: Du WW – PersonEntity: Name: NameFull: Sun RR – PersonEntity: Name: NameFull: Sun SY – PersonEntity: Name: NameFull: Zhang YW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2025 Nov-Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1551-4005 Numbering: – Type: volume Value: 24 – Type: issue Value: 21-24 Titles: – TitleFull: Cell cycle (Georgetown, Tex.) Type: main |
| ResultId | 1 |